175 related articles for article (PubMed ID: 24890258)
21. Circulating extracellular vesicles from patients with breast cancer enhance migration and invasion via a Src‑dependent pathway in MDA‑MB‑231 breast cancer cells.
Ramírez-Ricardo J; Leal-Orta E; Martínez-Baeza E; Ortiz-Mendoza C; Breton-Mora F; Herrera-Torres A; Elizalde-Acosta I; Cortes-Reynosa P; Thompson-Bonilla R; Perez Salazar E
Mol Med Rep; 2020 Sep; 22(3):1932-1948. PubMed ID: 32582965
[TBL] [Abstract][Full Text] [Related]
22. Levosimendan inhibits interleukin-1β-induced cell migration and MMP-9 secretion in rat cardiac fibroblasts.
Okada M; Suzuki A; Yamawaki H; Hara Y
Eur J Pharmacol; 2013 Oct; 718(1-3):332-9. PubMed ID: 24012928
[TBL] [Abstract][Full Text] [Related]
23. Zerumbone Suppresses Human Colorectal Cancer Invasion and Metastasis via Modulation of FAk/PI3k/NFκB-uPA Pathway.
Hosseini N; Khoshnazar A; Saidijam M; Azizi Jalilian F; Najafi R; Mahdavinezhad A; Ezati R; Sotanian A; Amini R
Nutr Cancer; 2019; 71(1):159-171. PubMed ID: 30650987
[TBL] [Abstract][Full Text] [Related]
24. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
Chiang KC; Yeh TS; Chen SC; Pang JH; Yeh CN; Hsu JT; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Sun CC; Juang HH
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110769
[TBL] [Abstract][Full Text] [Related]
25. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
[TBL] [Abstract][Full Text] [Related]
26. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
27. A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines.
Dehghan R; Najafi R; Azizi Jalilian F; Saidijam M; Radaei Z; Zamani A; Ezati R; Asna-Ashari F; Amini R
Mol Biol Rep; 2021 Jan; 48(1):203-218. PubMed ID: 33398678
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model.
Bouchard G; Therriault H; Geha S; Bérubé-Lauzière Y; Bujold R; Saucier C; Paquette B
BMC Cancer; 2016 Jun; 16():361. PubMed ID: 27282478
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-3 secretion from human pancreatic periacinar myofibroblasts in response to inflammatory mediators.
Inatomi O; Andoh A; Yagi Y; Ogawa A; Hata K; Shiomi H; Tani T; Takayanagi A; Shimizu N; Fujiyama Y
Pancreas; 2007 Jan; 34(1):126-32. PubMed ID: 17198194
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β.
Petrella BL; Vincenti MP
Cancer Med; 2012 Aug; 1(1):17-27. PubMed ID: 23342250
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-8-Induced Invasion Assay in Triple-Negative Breast Cancer Cells.
Uddin MM; Gaire B; Deza B; Vancurova I
Methods Mol Biol; 2020; 2108():107-115. PubMed ID: 31939174
[TBL] [Abstract][Full Text] [Related]
32. Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells.
Noori MS; O'Brien JD; Champa ZJ; Deosarkar SP; Lanier OL; Qi C; Burdick MM; Schwartz FL; Bergmeier SC; McCall KD; Goetz DJ
Eur J Pharmacol; 2017 May; 803():130-137. PubMed ID: 28343970
[TBL] [Abstract][Full Text] [Related]
33. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
35. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
[TBL] [Abstract][Full Text] [Related]
36. Zerumbone inhibits migration in ESCC via promoting Rac1 ubiquitination.
Wang M; Niu J; Gao L; Gao Y; Gao S
Biomed Pharmacother; 2019 Jan; 109():2447-2455. PubMed ID: 30551505
[TBL] [Abstract][Full Text] [Related]
37. CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells.
Armstrong DA; Phelps LN; Vincenti MP
Mol Cancer Res; 2009 Sep; 7(9):1517-24. PubMed ID: 19723873
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
[TBL] [Abstract][Full Text] [Related]
39. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
40. Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.
Sehrawat A; Sakao K; Singh SV
Breast Cancer Res Treat; 2014 Aug; 146(3):543-55. PubMed ID: 25038880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
